Abatacept in spondyloarthritis refractory to tumour necrosis factor alpha inhibition. | Ann Rheum Dis;68(1): 151-2, 2009 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Abatacept in spondyloarthritis refractory to tumour necrosis factor alpha inhibition.

Olivieri, I; D'Angelo, S; Mennillo, G A; Pistone, G; Scarano, E; Padula, A.

Ann Rheum Dis ; 68(1): 151-2, 2009 Jan.

Article in En | MEDLINE | ID: mdl-19088259

Subject(s)

Immunoconjugates/therapeutic use; Immunosuppressive Agents/therapeutic use; Spondylarthritis/drug therapy; Abatacept; Female; Humans; Spondylarthritis/immunology; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Spondylarthritis / Immunosuppressive Agents Limits: Female / Humans Language: En Journal: Ann Rheum Dis Year: 2009 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Spondylarthritis / Immunosuppressive Agents Limits: Female / Humans Language: En Journal: Ann Rheum Dis Year: 2009 Document type: Article